Perl Jeffrey, Jassal Sarbjit Vanita, Bargman Joanne M
Division of Nephrology, University Health Network, Toronto, Ontario, Canada.
Clin Transplant. 2008 Sep-Oct;22(5):672-3. doi: 10.1111/j.1399-0012.2008.00823.x. Epub 2008 Apr 23.
Patients returning to peritoneal dialysis after renal allograft loss are an increasing segment of the end-stage renal disease population. Non-transplant nephrologists will be managing the short- and long-term complications of chronic immunosuppression in these patients. In this case report, the use of sirolimus is described in a patient who developed a significant peritoneal dialysis catheter exit-site leak delaying the initiation of dialysis. The risk of impaired wound healing at the time of peritoneal dialysis catheter implantation must be considered when bridging patients from transplantation to peritoneal dialysis. Particular caution should be paid to the use of sirolimus during this period.
肾移植失败后重新开始腹膜透析的患者在终末期肾病群体中所占比例日益增加。非移植肾病专家将负责处理这些患者慢性免疫抑制带来的短期和长期并发症。在本病例报告中,描述了一名患者使用西罗莫司的情况,该患者出现了严重的腹膜透析导管出口处渗漏,推迟了透析的启动。在将患者从移植过渡到腹膜透析的过程中,必须考虑腹膜透析导管植入时伤口愈合受损的风险。在此期间使用西罗莫司时应格外谨慎。